Optimizing percutaneous coronary intervention outcomes: the next steps.
Vetrovec
George W
GW
D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000150:complications; D023903:Coronary Restenosis / Q000517:prevention & control; D018450:Disease Progression; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000209:etiology / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D012306:Risk; D015607:Stents; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors